Loading…
GoodRx Holdings, Inc. is projected to rise to $3.67 by 2027, a +28% move from its current price of $2.86. GDRX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $2.78 | $2.86 | $2.95 | +0.03% |
| May 30 | $2.74 | $2.86 | $2.99 | +0.06% |
| May 31 | $2.72 | $2.86 | $3.02 | +0.09% |
| Jun 1 | $2.70 | $2.86 | $3.04 | +0.12% |
| Jun 2 | $2.68 | $2.86 | $3.06 | +0.15% |
| Jun 3 | $2.66 | $2.87 | $3.08 | +0.18% |
| Jun 4 | $2.65 | $2.87 | $3.10 | +0.21% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.65 | $2.87 | $3.10 | +0.21% |
| Week 2 | $2.57 | $2.87 | $3.21 | +0.42% |
| Week 3 | $2.51 | $2.88 | $3.30 | +0.63% |
| Week 4 | $2.46 | $2.88 | $3.38 | +0.84% |
| Week 5 | $2.42 | $2.89 | $3.45 | +1.05% |
| Week 6 | $2.38 | $2.90 | $3.52 | +1.26% |
| Week 7 | $2.35 | $2.90 | $3.58 | +1.48% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscription programs and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform.
In addition, the company provides healthcare products and solutions for dogs, cats, and other pets. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.
GoodRx Holdings, Inc. is currently priced at $2.86 per share and carries a market cap of $968.61M, with a rank of 2531. The current price sits within a broader forecast that envisions a rising price path over time, with the 2026 average expected at $2.86 and a gradual increase through subsequent years.
By 2050, the average forecast price is $22.96, with a maximum forecast of $44.11 and a dramatic long‑term upside implied by the 702.8 ROI at 2050. The forecast also indicates a bullish sentiment in most years beyond 2026, suggesting a constructive long‑term outlook alongside a neutral near‑term stance in 2026.
A major floor 34.6% below — a decisive break under it would weaken the trend.
The nearest floor, 20.6% below — buyers have tended to step in here.
Price is pressing into resistance (2.1% away) — a breakout level to watch.
A major ceiling 16.6% above — clearing it would confirm fresh momentum.
Key GDRX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of GDRX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.67 | Buy | $2.72 | Buy |
| MA 10 | $2.59 | Buy | $2.65 | Buy |
| MA 20 | $2.60 | Buy | $2.58 | Buy |
| MA 50 | $2.34 | Buy | $2.46 | Buy |
| MA 100 | $2.37 | Buy | $2.53 | Buy |
| MA 200 | $2.99 | Sell | $2.97 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 66.66 | Neutral |
| Stoch RSI (14) | 64.06 | Neutral |
| CCI (20) | 125.18 | Buy |
| Williams %R (14) | -12.24 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | -2.05 | Sell |
| Bollinger %B (20,2) | 0.88 | Neutral |
| Stochastic %K (14) | 87.76 | Sell |
| TRIX (15) | 0.56 | Buy |
| Awesome (5,34) | 0.20 | Buy |
| Ultimate (7,14,28) | 83.54 | Sell |
| Momentum (10) | 0.17 | Buy |
| Aroon Osc (25) | 36.00 | Buy |
| Hull MA (9) | 2.79 | Buy |
| ADX (14) | 18.62 | Neutral |
| ATR (14) | 0.07 | Info |
The 30‑day technical picture shows bullish momentum, with RSI(14) at 70. The 50‑day simple moving average sits at $2.34 and the 200‑day simple moving average at $2.99, indicating a near-term rising trend relative to longer-term averages. Support is identified at $2.27 and resistance at $2.92, framing a modest trading range around the current level.
The 30‑day range spans from $2.34 to $3.49, reflecting a positive tilt but with potential volatility given the stock’s high annualized volatility of 60%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.87 | $2.86 | $4.02 | 0% | Neutral | |
| $2.88 | $3.67 | $4.97 | +28% | Bullish | |
| $3.35 | $4.39 | $6.18 | +54% | Bullish | |
| $3.82 | $5.15 | $7.47 | +80% | Bullish | |
| $3.64 | $5.02 | $7.47 | +75% | Bullish | |
| $3.69 | $5.19 | $7.91 | +82% | Bullish | |
| $4.02 | $5.76 | $8.96 | +102% | Bullish | |
| $4.04 | $5.90 | $9.34 | +106% | Bullish | |
| $4.70 | $6.98 | $11.23 | +144% | Bullish | |
| $5.44 | $8.21 | $13.43 | +187% | Bullish | |
| $6.25 | $10.19 | $17.80 | +256% | Bullish | |
| $12.33 | $22.96 | $44.11 | +703% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $1.87 | $2.86 | $3.38 | +0.00% |
| June 2026 | $2.50 | $2.94 | $3.55 | +2.91% |
| July 2026 | $2.47 | $2.94 | $3.60 | -0.14% |
| August 2026 | $2.56 | $3.06 | $3.79 | +4.23% |
| September 2026 | $2.64 | $3.18 | $3.97 | +3.70% |
| October 2026 | $2.57 | $3.11 | $3.92 | -2.08% |
| November 2026 | $2.52 | $3.06 | $3.89 | -1.63% |
| December 2026 | $2.57 | $3.15 | $4.02 | +2.82% |
Click any year to see its month-by-month GDRX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The GDRX price prediction for 2026 points to an average of $2.86 (low $1.87, high $4.02) — a potential gain of 0% on today's $2.86. Price action looks broadly range-bound.
In 2027, GDRX is projected to trade between $2.88 and $4.97, averaging $3.67 — a potential gain of +28% from today's $2.86. That is up +28% on the projected 2026 average. Buyers look set to stay in control over this stretch.
GoodRx Holdings, Inc.'s 2028 outlook centres on $4.39, within a $3.35 to $6.18 range. That is up +20% on the projected 2027 average. That marks a +54% change versus current levels. Momentum favours further upside here.
By 2029, GDRX could reach as high as $7.47, with a base case around $5.15 and support toward $3.82 — roughly +80% from $2.86. Buyers look set to stay in control over this stretch.
Expect GDRX to range from $3.64 to $7.47 through 2030. The $5.02 average target implies a +75% move from current prices. That is -3% versus the projected 2029 average. Momentum favours further upside here.
The GDRX price prediction for 2031 points to an average of $5.19 (low $3.69, high $7.91) — a potential gain of +82% on today's $2.86. Buyers look set to stay in control over this stretch.
In 2032, GDRX is projected to trade between $4.02 and $8.96, averaging $5.76 — a potential gain of +102% from today's $2.86. That is up +11% on the projected 2031 average. Momentum favours further upside here.
GoodRx Holdings, Inc.'s 2033 outlook centres on $5.90, within a $4.04 to $9.34 range. That is up +2% on the projected 2032 average. That marks a +106% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, GDRX could reach as high as $11.23, with a base case around $6.98 and support toward $4.70 — roughly +144% from $2.86. Momentum favours further upside here.
Expect GDRX to range from $5.44 to $13.43 through 2035. The $8.21 average target implies a +187% move from current prices. That is up +18% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The GDRX price prediction for 2040 points to an average of $10.19 (low $6.25, high $17.80) — a potential gain of +256% on today's $2.86. Momentum favours further upside here.
In 2050, GDRX is projected to trade between $12.33 and $44.11, averaging $22.96 — a potential gain of +703% from today's $2.86. That is up +125% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in GDRX today (≈ 349.65035 GDRX) could be worth
$8,027.53
+$7,027.53 (+703%) by 2050 · US Dollar
Based on the average projected GDRX price of $22.96 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in GDRXwould be worth at today's price.
$1,000 invested in GDRX on May 27, 2025 (≈ 261.096611 GDRX) would be worth
$746.74
-$253.26 (-25.3%) today · 0.75× · US Dollar
Based on a GDRX entry price of $3.83 vs. today's $2.86.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.52 | $1,134.92 | +13.5% |
| 1 month ago | $2.28 | $1,254.39 | +25.4% |
| 3 months ago | $1.99 | $1,437.19 | +43.7% |
| 6 months ago | $2.81 | $1,017.79 | +1.8% |
| 1 year ago | $3.83 | $746.74 | -25.3% |
| All time (5.0y) ago | $37.46 | $76.35 | -92.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our GDRX forecast.
Our base-case forecast reaches $5.70 around 2032.
Implied market cap at $5.70: $596.85M
The multi‑year forecast depicts a sustained upward trajectory, with the 2027 average at $3.67 and continuing to rise through the 2030–2035 window before accelerating toward the 2040s and beyond. Notably, 2030 carries an average forecast of $5.02 with a 75.4 ROI, while 2040 shows an average of $10.19 and a 256.3 ROI, and 2050 reaches an average of $22.96 with a 702.8 ROI. Across the horizon, the sentiment remains bullish, reflecting an expected long‑term appreciation despite near‑term variability.
These estimates are not guarantees and should be considered in the context of market risk and investor uncertainty.
Tap a question to reveal the answer.
2030 forecast: avg $5.02, min $3.64, max $7.47, ROI 75.4, sentiment BULLISH.
Forecasts show bullish sentiment in 2027 onward, with avg price rising to $22.96 by 2050 and ROI 702.8. These are estimates, not guarantees.
Yes. The 2040 forecast lists avg $10.19, with min $6.25, max $17.80 and ROI 256.3, sentiment BULLISH.
Current price is $2.86 and market cap is $968.61M.
The 2050 max forecast is $44.11.
GoodRx Holdings, Inc. Community Discussion
0Share your GoodRx Holdings, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.